Yang Hao,Shu Qiang,Guo Xiaodong.Recent advances in the treatment of infantile hemangiomas[J].Journal of Clinical Pediatric Surgery,,18():640-645.[doi:10.3969/j.issn.1671-6353.2019.08.005]
Click Copy

Recent advances in the treatment of infantile hemangiomas

Journal of Clinical Pediatric Surgery[ISSN:1671-6353/CN:43-1380/R] volume: 第18卷 Number: 2019 08 Page: 640-645 Column: 专题·脉管异常类疾病 Date of publication: 2019-08-25
Author(s):
Yang Hao1;  Shu Qiang2;  Guo Xiaodong3
1. Zhejiang University School of Medicine, Hangzhou 310058, China;
2. Children’s Hospital, Zhejiang University School of Medicine, Hangzhou, 310052, China;
3. Department of Pediatric Surgery, Jinhua Municipal Central Hospital, Jinhua 321000, China
Keywords:
Infant; Hemangioma/TH; Lasers; Drug/Beta Receptor Blockers; Surgical Procedures; Operative
CLC:
R543;R732.2
DOI:
10.3969/j.issn.1671-6353.2019.08.005
Abstract:
As one of the most common benign tumors during early infancy,infantile hemangiomas (IH) tend to undergo rapid growth followed by gradual involution.The complications of hemorrhage,ulceration,obstruction of airway,impairment of vision,disfigurement or even death require aggressive therapeutic interventions.Currently conventional treatments of IH include LASER,topical or oral medications,local injection therapy and surgical resection,etc.This article reviews the treatment options and recent advances of IH.

References:

1 Munden A,Butschek R,Tom WL,et al.Prospective study of infantile haemangiomas:incidence,clinical characteristics and association with placental anomalies[J].Br J Dermatol,2014,170(4):907-913.DOI:10.1111/bjd.12804.
2 Guo S,Ni N.Topical treatment for capillary hemangioma of the eyelid using beta-blocker solution[J].Arch Ophthalmol,2010,128(2):255-256.DOI:10.1001/archophthalmol.2009.370.
3 Borok J,Gangar P,Admani S,et al.Safety and efficacy of topical timolol treatment of infantile haemangioma:a prospective trial[J].Br J Dermatol,2018,178(1):e51-e52.DOI:10.1111/bjd.15865.
4 Droitcourt C,Kerbrat S,Rault C,et al.Safety of oral propranolol for infantile hemangioma[J].Pediatrics,2018,141(6):e20173783.DOI:10.1542/peds.2017-3783.
5 Ge J,Zheng J,Zhang L,et al.Oral propranolol combined with topical timolol for compound infantile hemangiomas:a retrospective study[J].Sci Rep,2016,6:19765.DOI:10.1038/srep19765.
6 Puttgen K,Lucky A,Adams D,et al.Topical timolol maleate treatment of infantile hemangiomas[J].Pediatrics,2016,138(3):e20160355.DOI:10.1542/peds.2016-0355.
7 Zheng L,Li Y.Effect of topical timolol on response rate and adverse events in infantile hemangioma:a meta-analysis[J].Arc Dermatol Res,2018,310(4):261-269.DOI:10.1007/s00403-018-1815-y.
8 王俞明,耿峰,查宗煜,等.0.5%噻吗洛尔溶液局部治疗婴幼儿血管瘤的疗效观察[J].组织工程与重建外科杂志,2012,8(04):208-212.DOI:10.3969/j.issn.1673-0364.2012.04.007.Wang YM,Geng F,Zha ZY,et al.Effectiveness of 0.5% solution of topical timolol maleate for infantile hemangiomas[J].Journal of Tissue Engineering & Reconstructive Surgery,2012,8(04):208-212.DOI:10.3969/j.issn.1673-0364.2012.04.007.
9 Frommelt P,Juern A,Siegel D,et al.Adverse events in young and preterm infants receiving topical timolol for infantile hemangioma[J].Pediatr Dermatol,2016,33(4):405-414.DOI:10.1111/pde.12869.
10 Rocco R,Alegre N,Pozner R,et al.Selective hemangioma cell dysfunction and apoptosis triggered by in vitro,treatment with imiquimod[J].Toxicol Lett,2018,288:82-88.DOI:10.1016/j.toxlet.2018.01.016.
11 Hu L,Huang HZ,Li X,et al.Open-label nonrandomized left-right comparison of imiquimod 5% ointment and timolol maleate 0.5% eye drops in the treatment of proliferating superficial infantile hemangioma[J].Dermatology,2015,230(2):150-155.DOI:10.1159/000369164.
12 Nguyen J,Fay A.Pharmacologic therapy for periocular infantile hemangiomas:a review of the literature[J].Semin Ophthalmol,2009,24(3):178-184.DOI:10.1080/08820530902805602.
13 Couto JA,Greene AK.Management of problematic infantile hemangioma using intralesional triamcinolone:efficacy and safety in 100 infants[J].J Plast Reconstr Aesthet Surg,2014,67(11):1469-1474.DOI:10.1016/j.bjps.2014.07.009.
14 杨耀武,郑家伟,孙沫逸,等.聚桂醇硬化剂治疗口腔颌面部血管瘤和脉管畸形专家共识[J].中国口腔颌面外科杂志,2018,16(3):275-278.DOI:10.19438/j.cjoms.2018.03.017.Yang YW,Zheng JW,Sun YM,et al.Expert consensus on the treatment of oral and maxillofacial hemangiomas and vascular malformations by lauromacrogol sclerotherapy[J].China Journal of oral and Maxillofac Surgery,2018,16(3):275-278.DOI:0.19438/j.cjoms.2018.03.017.
15 蔡仁慧,吕萍.聚桂醇泡沫硬化剂治疗婴幼儿血管瘤79例临床观察[J].中国皮肤性病学杂志,2017,31(7):740-742.DOI:10.13735/j.cjdv.1001-7089.201701035.Cai RH,Lv P.Efficacy of lauromacrogol foam sclerotherapy in the treatment of 79 cases of infantile hemangioma[J].Chin J Derm Venereol,2017,31(7):740-742.DOI:10.13735/j.cjdv.1001-7089.201701035.
16 Gao Z,Zhang Y,Li W,et al.Effectiveness and safety of polidocanol for the treatment of hemangiomas and vascular malformations:a meta-analysis[J].Dermatol Ther,2017,31(1):e12568.DOI:10.1111/dth.12568.
17 Qiu Y,Lin X,Ma G,et al.Eighteen cases of soft tissue atrophy after intralesional bleomycin a5 injections for the treatment of infantile hemangiomas:a long-term follow-up[J].Pediatr Dermatolo,2015,32(2):188-191.DOI:10.1111/pde.12422.
18 Pandey V,Tiwari P,Sharma SP,et al.Role of intralesional bleomycin and intralesional triamcinolone therapy in residual haemangioma following propranolol[J].Int J Oral Maxillofac Surg,2018,47(7):908-912.DOI:10.1016/j.ijom.2018.03.024.
19 董娟,纪尧峰.超声引导下射频消融治疗婴幼儿腮腺血管瘤[J].临床小儿外科杂志,2014,13(6):555-556.DOI:10.3969/j.issn.1671-6353.2014.06.027.Dong J,Ji YF.Ultrasound-guided RFA for the treatment of parotid gland hemangioma in infants[J].J Clin Ped Sur,2014,13(6):555-556.DOI:10.3969/j.issn.1671-6353.2014.06.027.
20 向芳,丁媛,于世荣.595 nm脉冲染料激光治疗婴幼儿皮肤真性血管瘤疗效观察[J].实用皮肤病学杂志,2014,7(4):291-293.DOI:10.11786/sypfbxzz.1674-1293.20140418.Xiang F,Ding Y,Yu SR.Curative effect analysis of 595 nm pulsed dye laser in the treatment of infantile hemangioma[J].Journal of Practical Dermatology,2014,7(4):291-293.DOI:10.11786/sypfbxzz.1674-1293.20140418.
21 Chinnadurai S,Sathe NA,Surawicz T.Laser treatment of infantile hemangioma:A systematic review[J].Lasers Surg Med,2016,48(3):221-233.DOI:10.1002/lsm.22455.
22 Li DN,Gold MH,Sun ZS,et al.Treatment of infantile hemangioma with optimal pulse technology[J].J Cosmet Laser Ther,2010,12(3):145-150.DOI:10.3109/14764172.2010.487908.
23 Zhong SX,Tao YC,Zhou JF,et al.Infantile Hemangioma:Clinical characteristics and efficacy of treatment with the long-pulsed 1,064-nm neodymium-doped yttrium aluminum garnet Laser in 794 Chinese patients[J].Pediatr Dermatol,2015,32(4):495-500.DOI:10.1111/pde.12593.
24 Stier MF,Glick SA,Hirsch RJ.Laser treatment of pediatric vascular lesions:Port wine stains and hemangiomas[J].J Am Acad Dermato,2008,58(2):261-285.DOI:10.1016/j.jaad.2007.10.492.
25 Ali A,Aiman U,Haseen MA,et al.The effect of oral propranolol versus oral corticosteroids in management of pediatric hemangiomas[J].World J Plast Surg,2018,7(1):16-24.
26 Greene AK,Couto RA.Oral prednisolone for infantile hemangioma:efficacy and safety using a standardized treatment protocol[J].Plast Reconstr Surg,2011,128(3):743-752.DOI:10.1097/PRS.0b013e3182221398.
27 Laken PA.Infantile hemangiomas:pathogenesis and review of propranolol use[J].Adv Neonatal Care,2016,16(2):135-142.DOI:10.1097/ANC.0000000000000254.
28 Liu X,Qu X,Zheng J,et al.Effectiveness and safety of oral propranolol versus other treatments for infantile hemangiomas:a meta-analysis[J].Plos One,2015,10(9):e0138100.DOI:10.1371/journal.pone.0138100.
29 Krowchuk DP,Frieden IJ,Mancini AJ,et al.Clinical Practice Guideline for the Management of Infantile Hemangiomas[J].Pediatr,2019,143(1):e20183475.DOI:10.1542/peds.2018-3475.
30 Oksiuta M,Matuszczak E,Debek W,et al.Treatment of problematic infantile hemangiomas with propranolol:a series of 40 cases and review of the literature[J].Postepy Hig Med Dosw,2014,68:1138-1344.DOI:10.5604/17322693.1120990.
31 Gonzalez-Llorente N,Del OI,Munoz-Ollero N,et al.Study of cognitive function in children treated with propranolol for infantile hemangioma[J].Pediatr Dermatol,2017,34(5):554-558.DOI:10.1111/pde.13229.
32 Hoeger PH,Harper JI,Baselga E,et al.Treatment of infantile haemangiomas:recommendations of a European expert group[J].Eur J Pediatr,2015,174(7):855-865.DOI:10.1007/s00431-015-2570-0.
33 郑家伟,杨秀娟.血管瘤的治疗选择[J].中国实用口腔科杂志,2009,2(5):274-279.DOI:10.3969/j.issn.1674-1595.2009.05.006.Zheng JW,Yang XJ.Selection of treatment modalities for infantile hemangiomas[J].Chinese Journal of Practical Stomatology,2009,2(5):274-279.DOI:10.3969/j.issn.1674-1595.2009.05.006.
34 李田园,贾仁兵,范先群.婴幼儿眼部血管瘤的治疗进展[J].临床眼科杂志,2017,25(6):560-564.DOI:10.3969/j.issn.1006-8422.2017.06.024.Li TY,Jia RB,Fan XQ.Advances in the treatment of periorbital infantile hemangiomas[J].Journal of Clinical Ophthalmology,2017,25(6):560-564.DOI:10.3969/j.issn.1006-8422.2017.06.024.
35 Tangtatco JA,Freedman C,Phillips J,et al.Surgical treatment outcomes of infantile hemangioma in children:does prior medical treatment matter[J].Pediatr Dermatol,2018,35(6):e418-e419.DOI:10.1111/pde.13658.
36 Lou H,Xu G,Huo R.Curative effect and safety of propranolol combined with prednisone in the treatment of infantile hemangiomas[J].Exp Ther Med,2018,15(6):4677-4682.DOI:10.3892/etm.2018.6035.
37 Li S,Xu G,Gao F,et al.Expression and association of VEGF-Notch pathways in infantile hemangiomas[J].Exp Ther Med,2017,14(4):3737-3743.DOI:10.3892/etm.2017.4943.
38 Bayart CB,Tamburro JE,Vidimos AT,et al.Atenolol versus propranolol for treatment of infantile hemangiomas during the proliferative phase:a retrospective noninferiority study[J].Pediatr Dermatol,2017,34(4):413-421.DOI:10.1111/pde.13177.

Memo

收稿日期:2018-12-18。
通讯作者:郭晓东,Emali:guoxiaodong@zju.edu.cn

Last Update: 1900-01-01